PUBLIC COMPANY
saveGenzyme Corp
updated 2mo ago
Genzyme was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world's third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme had a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products were also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products on the market.
community read0 votes
🐶 often sniffed alongside
top 4pipeline
14
marketed
12
phase 3
0
catalysts ytd
2
approvals ytd
2
recalls ytd
0
Pipeline(14)
view full pipeline →pipeline depth14 products
12Marketed2Unknown
Marketed
Lemtrada
Relapsing Remitting Multiple Sclerosis (RRMS)
MarketedLumizyme
Pompe Disease
Marketedagalsidase beta
Fabry Disease
Marketedalemtuzumab
B-Cell Chronic Lymphocytic Leukemia
Marketedanti-thymocyte globulin (rabbit)
Kidney Transplant Rejection
Marketedcaplacizumab
Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease)
Marketedfitusiran
Hemophilia A (Factor VIII Deficiency)
Marketedimiglucerase
Gaucher Disease Type III
Marketedlaronidase
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Marketedolipudase alfa
Niemann-Pick Disease Type B (Acid Sphingomyelinase Defici…
Marketedthyrotropin alfa
Thyroid Gland Disorders
Marketedvandetanib
Medullary Thyroid Cancer
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that